Mylan
- Awards
- 6
- Value outside frameworks
- Shared awards only
- Framework places
- 0
- Shared awards
- 6
Values exclude VAT where the notices give it, and only values in pounds are added up. A framework place carries the framework's whole ceiling, shared with the other suppliers on it, so framework places are counted rather than added up; so are awards made to several suppliers together. Every award here is a framework place or shared.
Awards
| Procurement | Buyer | Value | Date |
|---|---|---|---|
| NHS National Generic Pharmaceuticals - Clozapine shared | NHS England | - | 16 Jun 2025 |
| NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) shared | NHS England | - | 4 Mar 2024 |
| NHS National Generic Pharmaceuticals Wave 14b shared | Atamis Ltd | £428,226,984 | 7 Jul 2023 |
| NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection shared | NHS England | £27,009,807 | 28 Mar 2023 |
| NHS National Pharmaceuticals Transition 2022_2 shared | NHS England | £35,745,737 | 1 Nov 2022 |
| NHS National Pharmaceuticals Transition 2022_1 shared | NHS England and NHS Improvement | £39,636,345 | 19 Jul 2022 |
Top buyers
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 4 | - |
| Atamis Ltd | 1 | - |
| NHS England and NHS Improvement | 1 | - |
By number of awards. Value is the total of awards made to this supplier alone outside frameworks, excluding VAT where the notices give it.